Custom miRNA agomir synthesis provides chemically stabilized, double-stranded RNA constructs designed to increase the activity of a selected mature microRNA in gain-of-function research. Unlike a routine miRNA mimic, an agomir project may require coordinated guide-strand selection, passenger-strand engineering, ribose or backbone modification, optional lipid conjugation, high-resolution purification, duplex annealing, and analytical confirmation. These decisions directly affect nuclease resistance, strand loading, handling behavior, and the interpretability of downstream functional data.
Our custom miRNA agomir synthesis service supports biotechnology teams, pharmaceutical research groups, CROs, and academic laboratories from sequence review through purified duplex delivery. Projects can include species-specific agomirs, matched negative controls, cholesterol-conjugated formats, fluorescent tracking constructs, custom modification patterns, and research-scale packaging. Each program is planned around the intended model, route of use, readout, control strategy, and documentation requirements rather than relying on a single fixed agomir design.
Fig. 1 miRNA biogenesis and functions (Alsharafi WA, 2015)
Incorrect Mature-Strand Selection: A miRNA name alone may not define the required sequence. Species, 5p or 3p arm, database annotation, isomiR choice, and guide orientation must be confirmed before synthesis. We review the submitted miRNA identifier and sequence context to reduce the risk of ordering the wrong functional strand.
Passenger-Strand Activity: A duplex that loads both strands can generate unintended gene-regulation signals and complicate phenotype interpretation. We evaluate duplex asymmetry, passenger-strand design, terminal architecture, and modification placement to favor the intended guide strand while preserving productive duplex formation.
Over- or Under-Modification: Insufficient stabilization can lead to rapid degradation, while excessive or poorly placed modification can impair Argonaute loading and target regulation. Modification patterns are selected according to the research model, exposure needs, sequence, and delivery strategy rather than applied as a universal recipe.
Conjugate Handling Challenges: Cholesterol and other hydrophobic groups can improve membrane association but may also change solubility, purification behavior, recovery, and reconstitution. We plan linker placement, purification conditions, packaging format, and handling guidance around the final conjugated duplex.
Weak Experimental Controls: Agomir studies require chemistry-matched negative controls, suitable transfection or delivery controls, and readouts that distinguish target regulation from nonspecific responses. We help align control design with the agomir chemistry and can provide fluorescent tracking constructs or complementary miRNA antagomir synthesis for paired gain- and loss-of-function research.
Our service integrates sequence confirmation, strand-aware duplex design, RNA synthesis, chemical modification, conjugation, purification, annealing, and analytical quality review. The scope can be configured for a single research construct, a matched control set, or a small panel used to compare sequences, chemistries, labels, or delivery formats.
Project specifications are defined before synthesis so that each strand, modification, purification method, QC test, packaging format, and deliverable is traceable. Related work can also be coordinated with our custom RNA oligonucleotide synthesis capabilities when a program includes unmodified mimics, single-stranded RNA controls, or additional RNA reagents.
The preferred construct depends on whether the study prioritizes routine cell transfection, increased extracellular stability, delivery-oriented research, fluorescent tracking, or controlled comparison. The table below summarizes practical format choices without assuming that one chemistry is suitable for every miRNA sequence or model.
| Agomir Format | Best-Fit Research Need | Typical Design Features | Key Decision Factors | Recommended Deliverables |
| Standard miRNA Mimic Duplex | Initial cell-based gain-of-function experiments and assay optimization | Guide and passenger RNA strands with limited stabilization and standard duplex architecture | Transfection efficiency, short experimental window, passenger-strand behavior | Annealed duplex, negative control, strand purity data, sequence map |
| Stabilized miRNA Agomir | Studies requiring improved nuclease resistance or longer functional exposure | Selective ribose modifications, optional terminal backbone protection, strand-bias engineering | Modification tolerance, Argonaute loading, target regulation, model duration | Annealed duplex, chemistry-matched control, HPLC data, mass confirmation |
| Cholesterol-Conjugated Agomir | Delivery-oriented, membrane-association, or animal research workflows | Stabilized duplex with site-specific cholesterol and an appropriate linker | Conjugation site, solubility, formulation, administration route, tissue model | Conjugated duplex, matched control, reconstitution guidance, conjugate QC |
| Fluorescent Agomir | Uptake, localization, biodistribution, or transfection optimization studies | Dye-labeled strand with optional spacer and chemistry matched to the functional construct | Dye position, spectral compatibility, label stability, potential functional interference | Labeled duplex, unlabeled comparator, fluorophore details, analytical purity data |
| Agomir Screening Set | Comparison of sequences, modification patterns, conjugation formats, or dose-response behavior | Small panel produced with controlled differences and a shared control framework | Panel size, normalization strategy, assay throughput, decision criteria | Individually packaged duplexes, panel map, matched controls, comparative QC summary |
| Agomir and Antagomir Pair | Complementary gain- and loss-of-function analysis of the same miRNA | Duplex agomir plus a separately designed single-stranded inhibitory reagent | Different mechanisms, chemistry requirements, controls, and effective concentration ranges | Agomir, antagomir, separate matched controls, complete design documentation |
Agomir quality cannot be represented by a single purity number. Each strand must be traceable, the selected modifications must be confirmed, duplex assembly must be documented, and the final package must provide enough information for reconstitution, experimental planning, and repeat ordering.
| QC or Deliverable | What It Confirms | Typical Approach | Applied To | Reported Output |
| Sequence & Modification Map | Correct strand identity, orientation, termini, labels, and modification positions | Pre-production design review and lot-specific documentation | Every custom agomir and control | Confirmed sequence specification and final construct map |
| Strand Purity | Separation of full-length product from truncated or process-related species | Analytical HPLC or another fit-for-purpose chromatographic method | Guide strand, passenger strand, labeled or conjugated strand | Purity result and chromatographic trace where included |
| Molecular Mass | Consistency between the expected and observed molecular composition | Mass spectrometric analysis selected for the oligonucleotide format | Individual strands and selected conjugates | Expected mass, observed mass, and spectrum or summary |
| Duplex Assembly | Correct strand ratio and formation of the intended duplex | Controlled annealing, concentration-based mixing, and optional native analysis | Annealed agomir products | Annealing record and duplex-format declaration |
| Quantity or Concentration | Amount supplied for study planning and repeatable dosing preparation | UV absorbance, gravimetric assessment, or another agreed quantitation method | Lyophilized or solution-format products | Amount, concentration, volume, or optical-density information |
| Conjugate Review | Successful addition and recovery of cholesterol, dye, or other selected functional groups | Chromatographic and mass-based assessment as technically applicable | Cholesterol-conjugated and fluorescent agomirs | Conjugate identity summary and associated analytical data |
| Packaging & Handling Record | Correct tube allocation, form, labeling, and storage instructions | Final quality review against the confirmed project specification | All delivered materials | Tube map, product form, storage, and reconstitution guidance |
| Project Summary | Alignment between ordered design, produced material, QC scope, and delivered files | Documentation review before release | Single constructs, control sets, and screening panels | Consolidated lot summary with agreed supporting files |
The workflow connects biological intent with chemistry execution. Each stage resolves a specific decision before the project advances, helping avoid sequence errors, unsuitable modification patterns, mismatched controls, or incomplete analytical packages.
We collect the miRNA name or sequence, species, 5p or 3p designation, intended model, delivery approach, preferred scale, labels, controls, and downstream readouts. This establishes whether the project requires a standard mimic, stabilized agomir, conjugated construct, or comparative panel.
The mature guide sequence, passenger design, termini, overhangs, and sequence-dependent synthesis risks are reviewed. Any ambiguity in annotation or strand orientation is resolved before chemistry selection so the ordered material matches the intended miRNA function.
We define the strand-specific modification pattern, optional phosphorothioate positions, cholesterol or fluorescent conjugation, purification approach, control architecture, and QC package. The customer receives a clear construct map for review and confirmation.
Guide and passenger strands are synthesized independently, deprotected, processed, and purified using methods selected for the sequence and modification profile. Separate strand handling enables identity and purity review before duplex assembly.
Qualified strands are combined at the defined ratio and annealed under controlled conditions. Required analytical checks are completed for strand purity, molecular mass, conjugate identity, quantity, and duplex format before final packaging.
The final agomir is supplied with the agreed sequence map, analytical files, tube allocation, storage conditions, and reconstitution guidance. For projects requiring additional formulation planning, our RNA delivery system services can support research-stage carrier and delivery feasibility discussions.
Effective agomir synthesis requires more than producing two RNA strands. Our approach connects miRNA annotation, strand behavior, chemical stabilization, conjugation, controls, purification, and documentation so that the delivered construct is aligned with the intended experiment.
Custom agomirs are used when a study needs controlled enhancement of a selected miRNA pathway, particularly where unmodified RNA is too short-lived or where tracking and delivery features are required. Experimental design should account for the fact that a single miRNA can regulate multiple transcripts and that functional outcomes depend on cell type, model, exposure, and control selection.
Share the miRNA name or mature sequence, species, 5p or 3p designation, intended research model, preferred scale, modification needs, conjugation or label requirements, control strategy, and desired QC package. Our team will review the construct requirements and propose a practical synthesis plan covering strand design, chemistry, purification, annealing, packaging, and documentation. For broader experimental planning, our guide on how to study miRNA function can help organize complementary validation steps. Contact us to request a technical review and quotation for custom miRNA agomir synthesis.
miRNA Agomir is a specially labeled, chemically modified double-stranded small RNA that mimics endogenous miRNAs. It binds to target mRNA molecules and regulates gene expression by inhibiting translation, making it a powerful tool for gene silencing and regulation.
miRNA Agomir is widely used in research fields such as gene regulation, gene editing, and stem cell therapy. It can also be applied to study gene functions, explore regulatory networks, and enhance the specificity and longevity of RNA interference experiments.
miRNA Agomir offers broader targeting and longer-lasting effects compared to traditional siRNA. It is more stable, has higher affinity for cell membranes, and can achieve more efficient gene silencing with sustained interference lasting up to 5-6 weeks.
At BOC Sciences, miRNA Agomir is synthesized using advanced chemical methods and then purified through techniques like ion exchange chromatography and reverse-phase high-performance liquid chromatography (HPLC) to ensure high purity and activity.
We use mass spectrometry and nuclear magnetic resonance (NMR) to identify and confirm the purity and structure of synthesized miRNA Agomir. This ensures the product's quality and suitability for downstream applications.
Loading ......
